More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance?

  23 May 2024

With the antimicrobial research and development pipeline getting smaller, the Access to Medicine Foundation has released a new paper examining what can be done with the limited amount. The report describes how thorough access and stewardship planning may guarantee that newly-developed medications reach every patient who needs them, focusing on five late-stage programs that target some of the most severe drug-resistant infections.

Author(s): Access to Medicines Foundation
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed